← Open Payments lookup

PAUL KATZ: Open Payments

NPI 1629047154 · CECILTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$171 in 10 payments from 6 companies in 2025. Trend: 2023 $129 · 2024 $122 · 2025 $171

Food & beverage: $171
CompanyPaymentsAmount
Orexo US, Inc.3$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Otsuka America Pharmaceutical, Inc.2$33
Otsuka Pharmaceutical Development & Commercialization, Inc.1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
ABBVIE INC.1$16

Products named: REXULTI, Zubsolv, CAPLYTA, XIFAXAN, UBRELVY.

Industry payments across MD — which companies pay providers there.